Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
Chen ZN, Mi L, Xu J, Song F, Zhang Q, Zhang Z, Xing JL, Bian HJ, Jiang JL, Wang XH, Shang P, Qian AR, Zhang SH, Li L, Li Y, Feng Q, Yu XL, Feng Y, Yang XM, Tian R, Wu ZB, Leng N, Mo TS, Kuang AR, Tan TZ, Li YC, Liang DR, Lu WS, Miao J, Xu GH, Zhang ZH, Nan KJ, Han J, Liu QG, Zhang HX, Zhu P.
Chen ZN, et al. Among authors: li y, li l, li yc.
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):435-44. doi: 10.1016/j.ijrobp.2005.12.034.
Int J Radiat Oncol Biol Phys. 2006.
PMID: 16690431
Clinical Trial.